From: High-dose-rate brachytherapy for soft tissue sarcoma in children: a single institution experience
Patient/age | Diagnosis | Grade* | Implant site | Margins | CMT | Group* | HDRBT (Gy) | EBRT (Gy) | Local failure | Distant failure | DFS (mo) |
---|---|---|---|---|---|---|---|---|---|---|---|
female/9 | RMSE | III | Head neck | Negative | Yes | I | 18 | 41.4 | 159 | ||
female/16 | Synovial sarcoma | III | extremity | Negative | None | I | 24 | None | 19 | ||
Female/2 | ASPS | II | Extremity | Negative | Yes | I | 24 | None | 21 | ||
Female/14 | Synovial sarcoma | II | Extremity Hand | Positive | None | II | 24 | 41.4 | Lung | 45 | |
Male/5 | Synovial sarcoma | II | Head neck | Negative | Yes | I | 24 | None | 79 | ||
Female/12 | ASPS | III | Extremity | Negative | None | I | 18 | 30.6 | 29 | ||
Female/2 | RMSE | II | Pelvic | negative | Yes | I | 24 | None | 54 | ||
Male/4 | ASPS | II | Extremity | Positive | Yes | II | 24 | None | 143 | ||
female/1 | ASPS | III | Extremity | Positive | Yes | II | 30 | None | Lung | 18 | |
Male/2 | fibrosarcoma | II | Pelvic | Negative | Yes | I | 40 | None | 83 | ||
Female/11 | Synovia sarcomal | III | Extremity | Positive | Yes | II | 24 | 50 | 141 | ||
Female/9 | RMSE | III | Head Neck | Positive | Yes | III | 18 | 43.2 | 65 | ||
Female/12 | RMSE | III | Head Neck | positive | Yes | III | 18 | 45 | 94 | ||
Male/2 | ASPS | II | Pelvic | Negative | Yes | I | 21 | None | 12 | ||
Male/9 | Synovial sarcoma | II | Extremity | Negative | Yes | I | 30 | None | 114 | ||
Female/12 | RMS pleomorfic | II | Extremity | Negative | None | I | 21 | None | 80 | ||
Female/3 | Sarcoma indiferency | III | Extremity | Negative | Yes | I | 21 | 41.4 | Lung | 38 | |
female/16 | ASPS | III | Extremity | Positive | Yes | III | 24 | 50.0 | yes | NCS | 18 |